Targeted Delivery Platform
Effective delivery is not only about carrying a payload. The carrier must recognize the right cells, bind the right receptors, enter efficiently, and release its payload where it can act. FINNCURE’s technology is designed to address each of these steps.
How It Works
Targeting Design
Particle surfaces are functionalized to recognize and bind selectively to defined cellular receptors.
Particle Assembly
Therapeutic compounds are encapsulated into the carrier with a precise and controlled fabrication method.
Targeted Delivery
After administration, particles bind to target cells, enabling localized delivery of the therapeutic payload while reducing off-target exposure.
Cellular Uptake
Following receptor binding, particles are internalized into target cells through receptor-mediated endocytosis.
Intracellular
Payload Release
Once inside the cell, the therapeutic payload is released from the endosome into the cytoplasm, where it can exert its therapeutic effect
MANUFACTURING & SCALABILITY
Scalable Manufacturing
The proprietary manufacturing process enables high-yield production with precise control over particle size and structure. This ensures strong batch-to-batch reproducibility and supports scalable manufacturing.
PRECLINICAL VALIDATION
Studies Demonstrate Safety and Efficacy
Preclinical studies conducted at Charles River Laboratories have demonstrated selective binding to target cells, high cellular uptake, low toxicity, safe repeated dosing, and rapid degradation with minimal off-target accumulation.
INTELLECTUAL PROPERTY
Broad IP Protection
The platform is supported by several U.S. patents and a growing global portfolio covering targeting mechanisms and manufacturing technologies.